327 related articles for article (PubMed ID: 11688544)
1. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
[TBL] [Abstract][Full Text] [Related]
3. Functional and morphological effects of fotemustine on the auditory system of the rat.
Gocer C; Eryilmaz A; Kayikci ME; Korkmaz H; Surucu S; Akmansu SH
J Laryngol Otol; 2008 Jun; 122(6):551-6. PubMed ID: 17888195
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cisplatin ototoxicity in a rat animal model.
Hatzopoulos S; Di Stefano M; Albertin A; Martini A
Ann N Y Acad Sci; 1999 Nov; 884():211-25. PubMed ID: 10842595
[TBL] [Abstract][Full Text] [Related]
8. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
9. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
[TBL] [Abstract][Full Text] [Related]
10. Experimental otoacoustic emission and auditory brainstem response changes by stellate ganglion blockage in rat.
Firat Y; Kizilay A; Ozturan O; Ekici N
Am J Otolaryngol; 2008; 29(5):339-45. PubMed ID: 18722891
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.
Lorito G; Hatzopoulos S; Laurell G; Campbell KC; Petruccelli J; Giordano P; Kochanek K; Sliwa L; Martini A; Skarzynski H
Med Sci Monit; 2011 Aug; 17(8):BR179-186. PubMed ID: 21804453
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
Liao YJ; Tang H
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
[No Abstract] [Full Text] [Related]
14. [Research on DPOAE of guinea pigs treated with gentamicin].
Ye L; Tao Z; Hua Q; Xiao B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):57-60. PubMed ID: 18435257
[TBL] [Abstract][Full Text] [Related]
15. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
Riga M; Psarommatis I; Korres S; Lyra Ch; Papadeas E; Varvutsi M; Ferekidis E; Apostolopoulos N
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1003-8. PubMed ID: 16359737
[TBL] [Abstract][Full Text] [Related]
16. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
Mills DM
Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
Daldal A; Odabasi O; Serbetcioglu B
Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
[TBL] [Abstract][Full Text] [Related]
18. Relative ototoxicity of 21 aromatic solvents.
Gagnaire F; Langlais C
Arch Toxicol; 2005 Jun; 79(6):346-54. PubMed ID: 15660228
[TBL] [Abstract][Full Text] [Related]
19. Different strategies in treating noiseinduced hearing loss with N-acetylcysteine.
Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
Med Sci Monit; 2008 Aug; 14(8):BR159-64. PubMed ID: 18667992
[TBL] [Abstract][Full Text] [Related]
20. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
